https://doi.org/10.4081/aiua.2013.4.157
0
0
0
0
Smart Citations
0
0
0
0
Citing PublicationsSupportingMentioningContrasting
View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy

Authors

Raffaella Rossi
raffaella.rossi@hotmail.it
Department of Public Health and Infectious Diseases, “Sapienza” University, Rome, Italy.
Miriam Lichtner
Infectious Diseases Unit “Sapienza” University, Latina, Italy.
Francesco Iori
Department of Urology, “Sapienza” University, Rome, Italy.
Angela Ermocida
Department of Public Health and Infectious Diseases, “Sapienza” University, Rome, Italy.
Claudia Mascia
Department of Public Health and Infectious Diseases, “Sapienza” University, Rome, Italy.
Fabio Mengoni
Department of Public Health and Infectious Diseases, “Sapienza” University, Rome, Italy.
Ilaria Sauzullo
Department of Public Health and Infectious Diseases, “Sapienza” University, Rome, Italy.
Danilo Dini
Department of Urology, “Sapienza” University, Rome, Italy.
Claudio M. Mastroianni
Infectious Diseases Unit “Sapienza” University, Latina, Italy.
Vincenzo Vullo
Department of Public Health and Infectious Diseases, “Sapienza” University, Rome, Italy.
Objectives: Immunotherapy with BCG (Bacille Calmette-Guérin) after transurethral resection of the bladder tumor represents a highly effective primary treatment for intermediate and high-risk superficial bladder cancer. The effectiveness of this therapy has been documented, but its mechanism of action is not clear yet. In the present study, we investigated the changes of dendritic cells (DC) numbers in peripheral blood and urine of patients with superficial bladder cancer undergoing BCG intravescical therapy Material and method: We have enumerated plasmacytoid and myeloid DCs in the peripheral blood and in the urine of patients with bladder cancer in order to clarify the role of these cells in the evolution of the disease and the effect of therapy. DCs in blood and urine samples were assessed using the single-platform TruCOUNT assay with monoclonal antibodies. The study population included 37 healthy donors and 13 patients with diagnosis of primitive superficial bladder cancer. Results: At the time of diagnosis a reduction of blood DCs was found in patients as opposed to healthy donors, while DCs were not found in the urine in the same way as in healthy subjects. Six of these patients were followed before and after weekly and monthly instillations of BCG. In the peripheral blood, we observed an immunological recovery of DCs from the third weekly instillation up to the sixth. In the urine of patients, we didn’t find mDCs or pDCs at T0, but we found a statistically significant change from the third instillation up to the sixth. On the contrary, we didn’t find mDCs in urine during monthly instillation. Conclusions: DC Count could be used in the monitoring of patients undergoing BCG therapy. Immunological restoration of mDC numbers in peripheral blood and the efflux in urine could be important for confirming the effectiveness of BCG instillation.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
14
Scopus
0
Google Scholar
Europe PMC
Cláudia Martins-Lima, Ugo Chianese, Rosaria Benedetti, Lucia Altucci, Carmen Jerónimo, Margareta P. Correia (2023)
Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?. Frontiers in Molecular Biosciences, 9,
10.3389/fmolb.2022.1070383
Wenxin Ye, Li Chen, Chao Feng, Tiejun Liang (2021)
CircMYLK promotes the growth, migration, invasion, and survival of bladder cancer cells by upregulating CCND3 level via competitively binding to miR‐34a. Drug Development Research, 82(8), 1206.
10.1002/ddr.21835
Hui Wang, Zhao Hu, Li Chen (2018)
Enhanced plasma miR‑26a‑5p promotes the progression of bladder cancer via targeting PTEN. Oncology Letters,
10.3892/ol.2018.9163
Matilde Monti, Francesca Consoli, Raffaella Vescovi, Mattia Bugatti, William Vermi (2020)
Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma. Cells, 9(2), 417.
10.3390/cells9020417
Zhongbao Zhou, Yongjian Zhou, Xin Zhou, Yongjin Huang, Yuanshan Cui, Yong Zhang, Zhen-Jian Zhuo (2022)
Downregulation of PTCD1 in Bladder Urothelial Carcinoma Predicts Poor Prognosis and Levels of Immune Infiltration. Journal of Oncology, 2022, 1.
10.1155/2022/1146186
Li Zhou, Lin Lu, Max S Wicha, Alfred E Chang, Jian-chuan Xia, Xiubao Ren, Qiao Li (2015)
Promise of cancer stem cell vaccine. Human Vaccines & Immunotherapeutics, 11(12), 2796.
10.1080/21645515.2015.1083661
Magdalene Joseph, Deborah Enting (2019)
Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications. Frontiers in Oncology, 9,
10.3389/fonc.2019.01270
Laurent Derré, Ilaria Lucca, Valérie Cesson, Perrine Bohner, Francois Crettenand, Sonia-Cristina Rodrigues-Dias, Florence Dartiguenave, Audrey Masnada, Carla Teixeira-Pereira, Sulayman Benmerzoug, Mathieu F Chevalier, Sonia Domingos-Pereira, Sylvain Nguyen, Lenka Polak, Anna K Schneider, Patrice Jichlinski, Beat Roth, Denise Nardelli-Haefliger (2023)
Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential. Journal for ImmunoTherapy of Cancer, 11(12), e008020.
10.1136/jitc-2023-008020
Yujia Wang, Yu Zhao, Zixian Zhao, Dandan Li, Hao Nie, Yufen Sun, Xiaobei Feng, Ting Zhang, Yu Ma, Jing Nie, Guangyan Cai, Xiangmei Chen, Wei Zuo (2021)
Single-cell RNA-Seq analysis identified kidney progenitor cells from human urine. Protein & Cell, 12(4), 305.
10.1007/s13238-020-00816-5
David B Thompson, Larry E Siref, Michael P Feloney, Ralph J Hauke, Devendra K Agrawal (2015)
Immunological basis in the pathogenesis and treatment of bladder cancer. Expert Review of Clinical Immunology, 11(2), 265.
10.1586/1744666X.2015.983082
Yang Zhang, Fan Huo, Qiang Cao, Ru Jia, Qiju Huang, Zhu A Wang, Dan Theodorescu, Qiang Lv, Pengchao Li, Chao Yan (2022)
FimH confers mannose-targeting ability to Bacillus Calmette-Guerin for improved immunotherapy in bladder cancer. Journal for ImmunoTherapy of Cancer, 10(3), e003939.
10.1136/jitc-2021-003939
Ameer S. Sahib, Amjid Fawzi, Rahman S. Zabibah, Nisar Ahmad Koka, Shaymaa Abdulhameed Khudair, Faris Anad Muhammad, Doaa A. Hamad (2023)
miRNA/epithelial-mesenchymal axis (EMT) axis as a key player in cancer progression and metastasis: A focus on gastric and bladder cancers. Cellular Signalling, 112, 110881.
10.1016/j.cellsig.2023.110881
Matilde Monti, Giorgia Ferrari, Luisa Gazzurelli, Mattia Bugatti, Fabio Facchetti, William Vermi (2024)
Plasmacytoid dendritic cells at the forefront of anti-cancer immunity: rewiring strategies for tumor microenvironment remodeling. Journal of Experimental & Clinical Cancer Research, 43(1),
10.1186/s13046-024-03121-9
Yin Huaqi, Qin Caipeng, Wang Qiang, Du Yiqing, Xu Tao (2019)
The role of SOX18 in bladder cancer and its underlying mechanism in mediating cellular functions. Life Sciences, 232, 116614.
10.1016/j.lfs.2019.116614

How to Cite

Rossi, R., Lichtner, M., Iori, F., Ermocida, A., Mascia, C., Mengoni, F., Sauzullo, I., Dini, D., Mastroianni, C. M., & Vullo, V. (2013). Dendritic cells in blood and urine samples from bladder cancer patients undergoing BCG immunotherapy. Archivio Italiano Di Urologia E Andrologia, 85(4), 157–163. https://doi.org/10.4081/aiua.2013.4.157

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.